2020
S. A. Lakatosh et al. / Tetrahedron 61 (2005) 2017–2020
(2!75 ml). The extracts were dried over NaOH and
evaporated. 13 was separated from the starting aniline by
column chromatography (n-heptane/n-heptane–Et3N,
20:1) to give 13 as a dark oil (2.3 g, 18.4 mmol, 50%); dH
(CDCl3) 3.5 (1H, br s, NH), 6.66 (3H, d, Ph), 6.76 (2H, t,
Ph), 7.24 (3H,t, Ph); dC (CDCl3) 13.6–14.1 (m, –CD2CD3),
37.1–37.5 (m, –CD2CD3), 112.5 (2C), 117.0, 129.0 (2C),
148.3 (q).
3.1.5. 9-Benzyl-1,6-dideutero-2-hydro-6-(d3-methyl)-7-
phenyl-6H-pyrrolo[30,40:2,3][1,4]diazepino [6,7,1-hi]in-
dole-8,10(7H,9H)-dione (18). To the stirred solution of
15 (200 mg, 0.48 mmol) in CH2Cl2 (20 ml) was added TFA
(2 ml) and the mixture was left to stir for 8 h. The reaction
mixture was diluted with EtOAc (60 ml) and washed with
aq NaHCO3 (3!20 ml), water (20 ml) and brine; dried and
evaporated, the residue was chromatographed (n-heptane/
n-heptane–acetone, 10:1) to give 18 as a dark violet solid
(120 mg, 60%); mp 139–141 8C (cyclohexane), Rf 0.24
(n-heptane–EtOAc 6:1); m/z (EI HRMS) MC 426.2085
(C27H18D5N3O2 requires 426.2099) (100%), m/z (EI-MS)
MC 426 (100), MC (non-deuterated) 421 (15), MCKCD3
408 (30), MC (non-deuterated) KCH3 406 (9%).
3.1.3. 2-Dideutero-1,2-dihydro-7-ethyl-6,9-dimethyl-6H-
pyrrolo[30,40:2,3][1,4]diazepino[6,7,1-hi]indole-8,10-
(7H,9H)-dione (10). A solution of 3-(diethylamino)-4-(1H-
indol-1-yl)-1-methyl-1H-pyrrole-2,5-dione 8 (300 mg,
1 mmol) in CH2Cl2 (5 ml) was treated with CF3CO2D
(1 ml). The reaction mixture was left to stir overnight and
then poured into a mixture of EtOAc (50 ml) and aq
NaHCO3 (30 ml), the organic layer was separated, washed
with aq NaHCO3 (30 ml), water (30 ml), brine (30 ml) dried
over Na2SO4 and evaporated. The residue was purified by
column chromatography (n-heptane/n-heptane–acetone,
10:1) to give 10 as a dark violet solid (240 mg, 0.8 mmol,
80%); mp 80–82 8C (cyclohexane); Rf 0.41 (n-heptane–
EtOAc, 3:1); m/z (EI HRMS) MC 299.1614
(C17H17D2N3O2 requires 299.1601) (100), MCKCH3 284
(80), MCKNCH2CH3 256 (28), MCKC(O)NCH3 241
(50%).
Acknowledgements
This work was supported by Russian Foundation for Basic
Research, grant No. 03-03-32090-a. S. A. Lakatosh was also
supported by the Regional Social Fund for Support of
Russian Medical Science.
3.1.4. 1-Benzyl-3-[N-(d5-ethyl)aniline]-4-(1H-indol-1-yl)-
1H-pyrrole-2,5-dione (15). To the solution of 1-benzyl-3-
bromo-4-(1H-indol-1-yl)-1H-pyrrole-2,5-dione 14 (1.1 g,
2.7 mmol) in DMF (10 ml) were added N-(d5-ethyl)aniline
(0.5 g, 3.9 mmol) and ethyldiisopropylamine (1 ml). The
reaction mixture was stirred at 60 8C for 72 h and diluted
with EtOAc (50 ml) and water (20 ml). The organic layer
was separated and washed with 1 N HCl (2!10 ml), aq
NaHCO3 (10 ml), water (10 ml), brine (10 ml), dried and
evaporated. The residue was purified by chromatography
(n-heptane–EtOAc, 15:1) to give 15 as red crystals (0.8 g,
1.9 mmol, 70%); mp 112–114 8C (n-heptane–EtOAc); Rf
0.42 (n-heptane–EtOAc, 6:1); m/z (EI HRMS) MC
426.2087 (C27H18D5N3O2 requires 426.2099) (100),
MCKCD3 408 (11%).
Supplementary data
Supplementary data associated with this article can
References and notes
1. Lakatosh, S. A.; Luzikov, Y. N.; Preobrazhenskaya, M. N. Org.
Biomol. Chem. 2003, 1, 826–833.